Description
Health Supplement Medical Raw Material IDRA 21 Nootropic CAS 22503-72-6
Description
| Product Name: | IDRA 21 | Other Name: | 7-Chloro-3,4-dihydro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide |
|---|---|---|---|
| CAS No: | 22503-72-6 | MF: | C8H9ClN2O2S |
| MW: | 232.69 | Purity: | 99% Min |
| Shelf Life: | 2 Years | Application: | Pharmaceutical API |
| Sample: | Available | Storage: | Cool And Dry Place |
| High Light: |
Medical Raw Material CAS 22503-72-6, IDRA 21 Nootropic CAS 22503-72-6, Medical Raw Material IDRA 21 Nootropic |
||
Health Supplement Medical Raw Material Nootropics Powder CAS 22503-72-6 IDRA 21
Product Introduction
| Name | IDRA 21 |
| English synonyms | 7-Chloro-3,4-dihydro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide |
| CAS Number | 22503-72-6 |
| Molecular formula | C8H9ClN2O2S |
| Molecular weight | 232.69 |
| EINECS number | / |
Product Description
| Melting point | 209 °C(Solv: acetic acid (64-19-7)) |
| Specific Rotation | / |
| Optical Activity | / |
| Boiling point | 405.1±55.0 °C(Predicted) |
| Density | 1.394±0.06 g/cm3(Predicted) |
| Refractive Index | / |
| Solubility | / |
| Storage | Store at RT |
| Acidity coefficient (pKa) | 9.78±0.40(Predicted) |
| Color | White to off-white |
Product Function
IDRA-21 is an ampakine drug and a benzothiadiazinederivative. IDRA-21 is a chiral molecule, with (+)-IDRA-21 being the active form.
IDRA-21 shows nootropic effects in animal studies, significantly improving learning and memory. It is around 10-30 times more potent than aniracetam in reversing cognitive deficits induced by orscopolamine,and produces sustained effects lasting for up to 48 hours after a single dose.The mechanism for this action is thought to be through promoting the induction of long-term potentiation between synapses in the brain.
IDRA-21 does not produce neurotoxicity under normal conditions,although it may worsen neuronal damage following global ischemia after stroke or seizures.
